SEP 17, 2018 8:20 AM PDT

Daily Low-Dose Aspirin Not Effective In Prolonging Health

WRITTEN BY: Nouran Amin

A recent research study, published in The New England Journal of Medicine, found that the daily low-dose aspirin held no effects in healthy older adults. "Clinical guidelines note the benefits of aspirin for preventing heart attacks and strokes in persons with vascular conditions such as coronary artery disease," said NIA Director Richard J. Hodes, M.D. "The concern has been uncertainty about whether aspirin is beneficial for otherwise healthy older people without those conditions. This study shows why it is so important to conduct this type of research so that we can gain a fuller picture of aspirin's benefits and risks among healthy older persons."

The study began in 2010 and enrolled participants aged 70 and older with 65 being the minimum age of entry for African-American and Hispanic individuals in the United States due to their increased their risk of dementia and cardiovascular disease. At the time of enrolment in the study, participants must have been free from dementia, physical disability, and any other medical conditions requiring aspirin use. Furthermore, each participant was placed on a follow-up for an average of 4.7 years to determine outcomes. They were followed for an average of 4.7 years to determine outcomes. It was later found that these participants treated with 100 mg of low-dose aspirin daily have not improved the survival free of dementia or disability. The rates of physical disability and dementia were almost identical in the group that did not receive the daily low-dose aspirin as well as the rates of major cardiovascular events, such as coronary heart disease, nonfatal heart attacks, and fatal and nonfatal ischemic stroke.

Low dose aspirin. Credit: © elvis901 / Fotolia

The study also found a risk of significant bleeding with aspirin use as well as an increased risk of death from cancer. "The increase in cancer deaths in study participants in the aspirin group was surprising, given prior studies suggesting aspirin use improved cancer outcomes," explains Leslie Ford, M.D., associate director for clinical research, NCI Division of Cancer Prevention. "Analysis of all the cancer-related data from the trial is underway and until we have additional data, these findings should be interpreted with caution."

 

"These initial findings will help to clarify the role of aspirin in disease prevention for older adults, but much more needs to be learned,” says Evan Hadley, M.D., director of NIA's Division of Geriatrics and Clinical Gerontology.

Source: National Institute on Aging

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 06, 2020
Microbiology
JUN 06, 2020
Connecting Changes in Land Use to Emerging Diseases
It's estimated that an astonishing 75% of emerging pathogens that infect people are zoonotic - they originate in animals ...
JUN 15, 2020
Microbiology
JUN 15, 2020
Research Shows Wearing a Face Mask Reduces the Risk of COVID-19 Infection
We've known that face masks can reduce the likelihood that asymptomatic people will spread the illness. But they are als ...
JUN 16, 2020
Microbiology
JUN 16, 2020
Dexamethasone Hailed as Effective COVID-19 Treatment
The pandemic virus SARS-CoV-2, which causes COVID-19, has killed more than 438,000 people worldwide since it emerged lat ...
JUN 25, 2020
Immunology
JUN 25, 2020
The Protein That Orchestrates Cells' Dance of Death
When cells become diseased or infected, a “suicide switch” is triggered, preventing neighboring cells from b ...
JUL 03, 2020
Cancer
JUL 03, 2020
Using Machine Learning to Further Classify Triple-Negative Breast Cancer
One of the challenges of facing cancer researchers is coming up with a clearly defined classification system. Cancer is ...
JUL 01, 2020
Health & Medicine
JUL 01, 2020
New Venture Will Commercialize Products From Cannabis Research
Though the history of cannabis dates back at least three thousand years, the workings of the endocannabinoid system-the ...
Loading Comments...